Nippon India Nifty Pharma Etf Overview
Category Other ETFs
BMSMONEY Rank 8
Rating
Growth Option 07-03-2025
NAV ₹20.81(R) -0.22% (D) %
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 6.56% 18.16% -% -% -%
Direct
Benchmark
SIP (XIRR) Regular -6.25% 19.62% -% -% -%
Direct
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.53 0.29 0.66 -% -
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
17.37% -22.99% -15.21% - 11.95%
Top Other ETFs
Fund Name Rank Rating
Mirae Asset S&P 500 Top 50 ETF 1
- 2
Mirae Asset NYSE FANG+ ETF 3
ICICI Prudential Nifty Healthcare ETF 4
Aditya Birla Sun Life Nifty Healthcare ETF 5
Mirae Asset Nifty Financial Services ETF 6
Axis NIFTY Healthcare ETF 7
Nippon India Nifty Pharma ETF 8
ICICI Prudential Nifty India Consumption ETF 9
SBI Nifty Consumption ETF 10
Nippon India ETF Nifty India Consumption 11
UTI Nifty Bank ETF 12
Nippon India Nifty Auto ETF 13
Mirae Asset Nifty India Manufacturing ETF 14
Axis NIFTY India Consumption ETF 15
Kotak Nifty Midcap 50 ETF 16
UTI BSE Sensex Next 50 Exchange Traded Fund 17
SBI BSE Sensex Next 50 ETF 18
Nippon India Etf Nifty Midcap 150 19
Motilal Oswal Nifty Midcap 100 ETF 20

NAV Date: 07-03-2025

Scheme Name NAV Rupee Change Percent Change
Nippon India Nifty Pharma ETF 20.81
-0.0500
-0.2200%

Review Date: 07-03-2025

A review of the different performance parameters of the fund is as follows:
  1. Returns: It signifies the growth in the investment's value over a specific period, presented either as a percentage or a monetary figure. Our analysis focused on five return parameters of this fund. The return parameters have been categorized into three performance groups: the top 25%, those below the top 25% but above average, and those below average. Now, let's take a look at how each parameter has performed.
    1. Top 25%: The Nippon India Nifty Pharma ETF has two return parameters in the top 25% in the category, as shown below:
      • 1Y Return %
      • 3Y Return %
    2. Above Average Below the Top 25%: The Nippon India Nifty Pharma ETF has one return parameter in the category, which is above average but below the top 25%, as listed below:
      • 3M Return %
    3. Below Average: Nippon India Nifty Pharma ETF has two return parameters that are below average in the category, which are listed below:
      • 1M Return %
      • 6M Return %
  2. Risk: It is defined as the prospect of not attaining expected yields or enduring financial setbacks due to numerous causes. For Nippon India Nifty Pharma ETF, we have analyzed two risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: Nippon India Nifty Pharma ETF does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: Nippon India Nifty Pharma ETF does not have any risk parameters in the below average but above the lowest 25% of the category.
    3. Above Average: Nippon India Nifty Pharma ETF has two parameters that are above average which are listed below:
      • Standard Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the standard deviation, the greater the risk. The standard deviation of the fund is 17.37 %.
      • Semi-Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the semi-deviation, the greater the risk. The semi-deviation of the fund is 11.95 %.
  3. Risk Adjusted Performance Parameters: In mutual funds, risk-adjusted performance parameters are evaluation tools that gauge the returns of an investment against the risk taken. They assist investors in comparing various investments, factoring in both risk and returns. We have evaluated three risk-adjusted performance parameters of the fund.
    1. Top 25% Risk Adjusted Performance Parameters: Nippon India Nifty Pharma ETF has three risk-adjusted performance parameters of the fund that are in the top 25% of the category.
      • Sharpe Ratio: Nippon India Nifty Pharma ETF has a Sharpe Ratio of 0.53 compared to the category average of 0.29.
      • Sterling Ratio: Nippon India Nifty Pharma ETF has a Sterling Ratio of 0.66 compared to the category average of 0.46.
      • Sortino Ratio: Nippon India Nifty Pharma ETF has a Sortino Ratio of 0.29 compared to the category average of 0.14.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.


Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Nippon India Nifty Pharma Etf NAV Regular Growth Nippon India Nifty Pharma Etf NAV Direct Growth
07-03-2025 20.8075 None
06-03-2025 20.8536 None
05-03-2025 20.551 None
04-03-2025 20.2386 None
03-03-2025 20.2991 None
28-02-2025 20.2317 None
27-02-2025 20.6275 None
25-02-2025 20.6767 None
24-02-2025 20.8202 None
21-02-2025 20.8165 None
20-02-2025 21.2249 None
19-02-2025 21.2599 None
18-02-2025 21.4123 None
17-02-2025 21.521 None
14-02-2025 21.2517 None
13-02-2025 21.8739 None
12-02-2025 21.5833 None
11-02-2025 21.693 None
10-02-2025 22.117 None
07-02-2025 22.5365 None

Fund Launch Date: 02/Jul/2021
Fund Category: Other ETFs
Investment Objective: The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the Nifty Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
Fund Description: An open ended scheme replicating/ tracking NIFTY Pharma Index
Fund Benchmark: Nifty Pharma Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.